These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 19174777)

  • 1. Pharmacogenomic progress in individualized dosing of key drugs for cancer patients.
    Walko CM; McLeod H
    Nat Clin Pract Oncol; 2009 Mar; 6(3):153-62. PubMed ID: 19174777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacogenetics in cancer chemotherapy: balancing toxicity and response.
    Donnelly JG
    Ther Drug Monit; 2004 Apr; 26(2):231-5. PubMed ID: 15228171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacogenomic applications in oncology.
    Walko CM; Ikediobi O
    J Pharm Pract; 2012 Aug; 25(4):439-46. PubMed ID: 22907843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacogenomics in cancer therapy: is host genome variability important?
    Petros WP; Evans WE
    Trends Pharmacol Sci; 2004 Sep; 25(9):457-64. PubMed ID: 15559247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Anticancer drug dosing--pharmacogenomic biomarkers or body surface area?].
    Lehne G; Bjørheim J; Saeter G
    Tidsskr Nor Laegeforen; 2007 Apr; 127(8):1040-4. PubMed ID: 17457389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacogenomics, Pharmacokinetics, and Pharmacodynamics in the Era of Targeted Therapies.
    Calvo E; Walko C; Dees EC; Valenzuela B
    Am Soc Clin Oncol Educ Book; 2016; 35():e175-84. PubMed ID: 27249721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer pharmacogenomics: achievements in basic research.
    Nakajima M; Yokoi T
    Int J Clin Oncol; 2005 Feb; 10(1):14-9. PubMed ID: 15729595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pharmacogenetics in oncology].
    Morán González D; Jiménez Cabrera S; Domínguez-Gil Hurlé A
    Med Clin (Barc); 2008 Jul; 131(5):184-95. PubMed ID: 18674490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer treatment and pharmacogenetics of cytochrome P450 enzymes.
    van Schaik RH
    Invest New Drugs; 2005 Dec; 23(6):513-22. PubMed ID: 16267627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacogenetics for individualized cancer chemotherapy.
    Efferth T; Volm M
    Pharmacol Ther; 2005 Aug; 107(2):155-76. PubMed ID: 15890408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacogenetic and Pharmacokinetic Dose Individualization of the Taxane Chemotherapeutic Drugs Paclitaxel and Docetaxel.
    Andriguetti NB; Raymundo S; Antunes MV; Perassolo MS; Verza SG; Suyenaga ES; Linden R
    Curr Med Chem; 2017; 24(33):3559-3582. PubMed ID: 28641556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacogenetics in cancer treatment.
    Nagasubramanian R; Innocenti F; Ratain MJ
    Annu Rev Med; 2003; 54():437-52. PubMed ID: 12525681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer pharmacogenomics: international trends.
    Yamayoshi Y; Iida E; Tanigawara Y
    Int J Clin Oncol; 2005 Feb; 10(1):5-13. PubMed ID: 15729594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacogenomics of sex difference in chemotherapeutic toxicity.
    Wang J; Huang Y
    Curr Drug Discov Technol; 2007 Jun; 4(1):59-68. PubMed ID: 17630929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Personalizing chemotherapy dosing using pharmacological methods.
    Patel JN; Papachristos A
    Cancer Chemother Pharmacol; 2015 Nov; 76(5):879-96. PubMed ID: 26298089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacogenetics of Drugs Used in the Treatment of Cancers.
    Franczyk B; Rysz J; Gluba-Brzózka A
    Genes (Basel); 2022 Feb; 13(2):. PubMed ID: 35205356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toward individualized treatment: prediction of anticancer drug disposition and toxicity with pharmacogenetics.
    Deeken JF; Figg WD; Bates SE; Sparreboom A
    Anticancer Drugs; 2007 Feb; 18(2):111-26. PubMed ID: 17159598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pharmacogenetics of anticancer drugs].
    de Chaisemartin L; Loriot MA
    Pathol Biol (Paris); 2005 Mar; 53(2):116-24. PubMed ID: 15708657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analyzing the clinical actionability of germline pharmacogenomic findings in oncology.
    Wellmann R; Borden BA; Danahey K; Nanda R; Polite BN; Stadler WM; Ratain MJ; O'Donnell PH
    Cancer; 2018 Jul; 124(14):3052-3065. PubMed ID: 29742281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Part 3: Pharmacogenetic variability in phase II anticancer drug metabolism.
    Deenen MJ; Cats A; Beijnen JH; Schellens JH
    Oncologist; 2011; 16(7):992-1005. PubMed ID: 21659608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.